Compartir
Información de la revista
Número
Vol. 28. Núm. 4.(julio - agosto 2023)
Editorial
A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD
Ann Hepatol. 2023;28:101115
Acceso a texto completo
Opinions
The leading and key role of hepatologists in the multidisciplinary management of patients with hepatocellular carcinoma
Juan Ignacio Marín, Margarita Anders, Aline Chagas, Josemaría Menéndez, Oscar Beltran, Enrique Carrera Estupiñan, Javier Diaz Ferrer, Angelo A. Mattos, ... special group of interest of liver cancer from the American Association Study for Liver Diseases (ALEH)
Ann Hepatol. 2023;28:101112
Acceso a texto completo
Original articles
Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study
Yongwu Chen, Xiuli Yang, Yanfei Shao, Hongying Zhao, Jinying Jiang, Ping Huang, Yi Lu, Zixue Xuan
Ann Hepatol. 2023;28:101099
Acceso a texto completo
Early living donor liver transplantation for alcohol-associated hepatitis
Anand V. Kulkarni, Raghuram Reddy, Juan Pablo Arab, Mithun Sharma, Sameer Shaik, Sowmya Iyengar, Naveen Kumar, , ... K. Rajender Reddy
Ann Hepatol. 2023;28:101098
Acceso a texto completo
Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
Carolina Vazquez, María Nelly Gutierrez-Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, José Luis Fernandez, María Margarita Anders, Nadia Lorena Grigera, ... Sebastián Marciano
Ann Hepatol. 2023;28:101097
Acceso a texto completo
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome
Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, ... Members of the Brazilian Cholestasis Study Group Consortium
Ann Hepatol. 2023;28:101105
Acceso a texto completo
Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis
Luis Antonio Manzo-Francisco, Jorge Aquino-Matus, Dèsirée Vidaña-Pérez, Misael Uribe, Norberto Chavez-Tapia
Ann Hepatol. 2023;28:101107
Acceso a texto completo
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study
Ke Su, Qiuni Shen, Jian Tong, Tao Gu, Ke Xu, Han Li, Hao Chi, Yanlin Liu, ... Yunwei Han
Ann Hepatol. 2023;28:101109
Acceso a texto completo
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC
Federico Piñero, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal
Ann Hepatol. 2023;28:101110
Acceso a texto completo
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)
James M. Paik, Katherine E Eberly, Khaled Kabbara, Michael Harring, Youssef Younossi, Linda Henry, Manisha Verma, Zobair M. Younossi
Ann Hepatol. 2023;28:101108
Acceso a texto completo
Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina
Federico Guillermo Villamil, Manuel Barbero, Nancy Elena Massenzio, Sandra Mónica Giani, Shigeru Kozima, Fernando Mario Cairo, Rodrigo Agustín Belloni, Javier Mariani, ... Patricia Eugenia Gallardo
Ann Hepatol. 2023;28:101111
Acceso a texto completo
Letters to the editor
Comment on “Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c”
Zhenjing Wang, Nai Liu, Caixia Guo
Ann Hepatol. 2023;28:101113
Acceso a texto completo
Reply to: Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c
Hirsh D. Trivedi, Michelle Lai
Ann Hepatol. 2023;28:101114
Acceso a texto completo
Special issue on genomic medicine in obesity and chronic liver damage
Prevalence of liver cirrhosis based on the metabolic health and weight criteria: Report from the Korea National Health and Nutrition Examination Survey (KNHANES) data analysis
Hyukjin Mun, Eun Sun So
Ann Hepatol. 2023;28:100721
Acceso a texto completo
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease
Dongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao
Ann Hepatol. 2023;28:100726
Acceso a texto completo
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents
Diego García-Compeán, Ramesh Kumar, Ángel Noe del Cueto-Aguilera, Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez
Ann Hepatol. 2023;28:100751
Acceso a texto completo
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
Acceso a texto completo
Late evening snack and oral amino acid capsules improved respiratory quotient and Fischer ratio in patients with alcoholic liver cirrhosis
Juan Zhao, Jing Wu, Juan Li, Zhong-Ying Wang, Qing-Hua Meng
Ann Hepatol. 2023;28:100750
Acceso a texto completo
Publique en
Annals of Hepatology
Affiliated societies
